Geneve J, Le Dinh T, Brouard A, Bails M, Segrestaa J M, Caulin C
Clinique Thérapeutique, Hôpital Lariboisiere, Paris, France.
Br J Clin Pharmacol. 1990 Aug;30(2):297-300. doi: 10.1111/j.1365-2125.1990.tb03779.x.
Enalapril maleate, an angiotensin converting enzyme inhibitor, is a vasodilator liable to modify regional blood flow. The effects of an oral dose of 40 mg enalapril maleate on indocyanine green (ICG) kinetics were assessed in nine healthy subjects. At 4 h after the administration of the drug, a 35% decrease in ICG clearance was observed (P less than 0.01) associated with a 23% decrease in its volume of distribution (P less than 0.02). The half-life of ICG was not altered significantly by enalapril. These results suggest that the administration of enalapril maleate to healthy subjects may reduce apparent liver plasma flow and plasma volume, as a consequence of the pooling of blood in the hepatosplanchnic area.
马来酸依那普利是一种血管紧张素转换酶抑制剂,是一种易于改变局部血流的血管扩张剂。在9名健康受试者中评估了口服40mg马来酸依那普利对吲哚菁绿(ICG)动力学的影响。给药后4小时,观察到ICG清除率下降35%(P<0.01),同时其分布容积下降23%(P<0.02)。依那普利对ICG的半衰期没有显著影响。这些结果表明,健康受试者服用马来酸依那普利可能会减少肝脏表观血浆流量和血浆量,这是肝内脏区域血液淤积的结果。